Cargando…
Structure–Activity Relationship of Synthetic Ginkgolic Acid Analogs for Treating Type 2 Diabetes by PTPN9 Inhibition
Ginkgolic acid (C13:0) (GA), isolated from Ginkgo biloba, is a potential therapeutic agent for type 2 diabetes. A series of GA analogs were designed and synthesized for the evaluation of their structure–activity relationship with respect to their antidiabetic effects. Unlike GA, the synthetic analog...
Autores principales: | Kim, Jinsoo, Son, Jinyoung, Ahn, Dohee, Nam, Gibeom, Zhao, Xiaodi, Park, Hyuna, Jeong, Woojoo, Chung, Sang J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999917/ https://www.ncbi.nlm.nih.gov/pubmed/35409287 http://dx.doi.org/10.3390/ijms23073927 |
Ejemplares similares
-
Ethyl Gallate Dual-Targeting PTPN6 and PPARγ Shows Anti-Diabetic and Anti-Obese Effects
por: Ahn, Dohee, et al.
Publicado: (2022) -
Identification of Crocetin as a Dual Agonist of GPR40 and GPR120 Responsible for the Antidiabetic Effect of Saffron
por: Zhao, Xiaodi, et al.
Publicado: (2023) -
Chebulinic Acid Suppresses Adipogenesis in 3T3-L1 Preadipocytes by Inhibiting PPP1CB Activity
por: Kim, Jinsoo, et al.
Publicado: (2022) -
Ginkgolic acid inhibits fusion of enveloped viruses
por: Borenstein, Ronen, et al.
Publicado: (2020) -
Pharmacological Activities of Ginkgolic Acids in Relation to Autophagy
por: Ding, Yuan, et al.
Publicado: (2022)